IN8BIO, INC. Quarterly Operating Income (Loss) in USD from Q2 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
In8 Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q2 2024.
- In8 Bio, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$8.63M, a 11.8% decline year-over-year.
- In8 Bio, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$32.3M, a 6.08% decline year-over-year.
- In8 Bio, Inc. annual Operating Income (Loss) for 2023 was -$30.3M, a 6.37% decline from 2022.
- In8 Bio, Inc. annual Operating Income (Loss) for 2022 was -$28.5M, a 94.6% decline from 2021.
- In8 Bio, Inc. annual Operating Income (Loss) for 2021 was -$14.7M, a 71.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)